HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Siremadlin

HCID 71678098
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1448867-41-1
Standard SMILES
COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1
InChIKey
AGBSXNCBIWWLHD-FQEVSTJZSA-N
Molecular formula
C26H24Cl2N6O4
Average molar mass
555.4 g/mol
Monoisotopic mass
554.1236087

Overview

Siremadlin is an orally bioavailable human double minute 2 homolog (HDM2) inhibitor with potential antineoplastic activity. Siremadlin inhibits the binding of the HDM2 protein to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this HDM2-p53 interaction, the proteasome-mediated enzymatic degradation of p53 is inhibited, which may result in the restoration of both p53 signaling and p53-mediated induction of tumor cell apoptosis. HDM2, a zinc finger protein and negative regulator of the p53 pathway, is often overexpressed in cancer cells and has been implicated in cancer cell proliferation and survival.

Names & identifiers

Preferred name
Siremadlin
IUPAC
(4S)-5-(5-chloro-1-methyl-2-oxo-3-pyridinyl)-4-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-3-propan-2-yl-4H-pyrrolo[3,4-d]imidazol-6-one
English name
Siremadlin
Molecular formula
C26H24Cl2N6O4
Molecular weight
555.41

Names & synonyms

Siremadlin1448867-41-1NVP-HDM 201HDM-201HDM201siremadlinasiremadline0282IF4JC8Hdm 201Pyrrolo[3,4-d]imidazol-4(1H)-one, 5-(5-chloro-1,2-dihydro-1-methyl-2-oxo-3-pyridinyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxy-5-pyrimidinyl)-5,6-dihydro-1-(1-methylethyl)-, (6S)-Pyrrolo(3,4-d)imidazol-4(1H)-one, 5-(5-chloro-1,2-dihydro-1-methyl-2-oxo-3-pyridinyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxy-5-pyrimidinyl)-5,6-dihydro-1-(1-methylethyl)-, (6S)-siremadlinum
Show more names
CS-2787CS-2613Siremadlin,HDM 201NVP-HDM201 S-ISOMERHDM201 (Siremadlin)Siremadlin (NVP-HDM201)HDM201 (Siremadlin) HCl
RefChem:183233NVP-HDM201(S)-5-(5-Chloro-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-isopropyl-5,6-dihydropyrrolo[3,4-d]imidazol-4(1H)-oneSiremadlin [USAN]MFCD30502893WHO 10869(6S)-5-(5-chloro-1,2-dihydro-1-methyl-2-oxo-3-pyridinyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxy-5-pyrimidinyl)-5,6-dihydro-1-(1-methylethyl)-Pyrrolo[3,4-d]imidazol-4(1H)-oneHY-18658

Properties

Computed structural propertiesFilling in

XLogP
3.6
Topological polar surface area
103 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
7
Rotatable bonds
6
Heavy atoms
38
Formal charge
0
Complexity
987

Physicochemical properties

Boiling point
736.5 · 736.5±70.0 °C(Predicted)
Density
1.47 · 1.47±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
56.75 mg/mL · DMSO : ≥ 56.75 mg/mL (102.18 mM)
pka
1.33 · 1.33±0.29(Predicted)
form
Solid
color
White to off-white
InChIKey
AGBSXNCBIWWLHD-FQEVSTJZSA-N
SMILES
C1(C2=CN=C(OC)N=C2OC)=NC2C(=O)N(C3=CC(Cl)=CN(C)C3=O)[C@@H](C3=CC=C(Cl)C=C3)C=2N1C(C)C
FDA UNII
282 IF4JC8 · 0282IF4JC8
NCI Drug Dictionary
siremadlin
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P280-P301+P312-P302+P352-P305+P351+P338

Chemistry & industry

Applications · 1 item

UsesSiremadlin is an oral biologic agent that is a selective inhibitor of the p53-MDM2 interaction and is being investigated for the treatment of patients with myeloid malignancies after showing single agent activity in preclinical studies. the safety profile of Siremadlin did not differ significantly between tumor types and treatment regimens.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1448867-41-1
PubChem CID
71678098
ChEMBL
CHEMBL3653256
UNII
0282IF4JC8
Nikkaji
J3.619.530D
261 · P261-P280-P301+P312-P302+P352-P305+P351+P338